PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes
Summary
PTC Therapeutics priced $500 million of 0% convertible senior notes due 2031 in a private placement. The company plans to use most of the proceeds to repurchase or repay its 2026 convertible notes. It also entered into private repurchase transactions for about $328.8 million of the older notes. The remaining proceeds will support general corporate purposes and possible future note repurchases. This announcement reflects balance-sheet management rather than a product, acquisition, or personnel change.
Funding
Amount
$500.0M
Total raised
Date
June 15, 2026
Announcement date
Investors
-
Lead investors
Company
ptct.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected